Form 4 for NXL Nexalin Technology, Inc.
Accepted 2024-08-15 00:00:00 ET · period of report 2024-08-13 · accession 0001829126-24-005573 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-08-15 | 2024-08-13 | NXL | Owens David | Chief Medical Off, Dir | P - Purchase | $0.95 | +1,000 | 147.8K | +0.7% | +$950 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2024-08-13 | P | A | 1,000 | $0.95 | 147,793 | D | — | — |